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Third European Congress of
Clinical Chemistry
The Congress was held from the 4-8 June 1979 at the
Metropole Hotel, Brighton, UK. After an introductory
speech by Professor T.P. Whitehead and a welcome from
Professor B.E. Clayton for the Association of Clinical
Biochemists. Dr. R. Dybkaer, President of the International
Federation of Clinical Chemistry, then officially opened the
Congress. The Congress was organised to provide a good mix
of scientific communication in the form of Plenary lectures
by distinguished scientists, Symposia on selected topics,
Seminars by industrial contributors and Contributed Paper
sessions by scientists with a wide range of interests. The
latter three groups generally ran in parallel with each other
and with Poster sessions covering a wide range of topics.
Throughout the period of the Congress a massive exhibition
of clinical chemistry instrumentation was held on two floors.
A fine social programme included a formal banquet and an
outing to the 200th Derby. Whilst the objective of this
report is specifically related to automation it is necessary to
note the plenary lectures.
Astrup [1] in his plenary lecture drew attention to both
the criticisms and advantages of modern trends in clinical
chemistry. Porter [2] gave a fine plenary lecture in which he
showed the way x-ray crystallographic studies are elucidating
the mechanism of antibody/antigen binding and the
structure, assembly and mode of activiation of the compon-
ents of complement. A highlight of the Congress was the
superb lecture given by Galjaard [3].Advances now make it
possible to diagnose many metabolic disorders by genetic
counselling prior to conception, tests on cells and cord blood
in utero and on patients either at risk or with overt
symptoms.
Marks [4] discussed the rapidly growing area of drug.
monitoring in which clinical chemistry is more concerned
with treatment than diagnosis. Thore [5] in his plenary
lecture gave an excellent account of the emerging science
of luminescence in clinical chemistry.
Lever [6] in a controversial plenary lecture outlined
the criteria for classifying hypertension and then presented
evidence to cast doubt on the sub-division of essential
hypertension into low-renin and normo-renin forms,
Granstrom 7] gave a lucid account of the start of the art in
prostaglandin and thromboxane research. Lever [8] in
discussing renal failure drew attention to the isolation of
a chromatographic fraction of M W 1000- 1500 with the
ability to inhibit haemoglobin formation.
The International Federation of Clinical Chemistry
organised a symposium on ’Decision Criteria for Selecting
Analytical Instruments’ in which members of the Expert-
Panel on Instrumentation detailed the ways in which more
informed decisions on the choice of costly automatic
equipment can be made, to suit the needs of each laborat-
ory. A starting point is to encourage manufacturers to
provide the right information; the use of cost/benefit studies
was considered important; the value of sound evaluations and
contact with colleagues with previous experience of intended
purchase was emphasised. Finally education of laboratory
managers to consider the effects on laboratory organisation
was underlined and in this, computer simulation studies are
proving valuable. Papers in this session will be published in
the Journal of Automatic Chemistry 1979 October issue.
A symposium on techniques in data handling included
a contribution by Lave [9] on the relativements of bar
coding and other techniques. The size of each code can be a
problem and the desirability of having human readable code
additionally, was emphasised. Knill-Jones [10] discussed
clinical aspects of data reduction and an excellent contrib-
ution by Healy [11] highlighted the use and abuse of
statistics in clinical chemistry. Hall 12 produced some
interesting thoughts on the use of computers to find trends
in health and disease over a period of time at the individual
level and so circumvent the vagaries of the normal range.
A symposium on approaches in clinical chemistry
analytical techniques included an account of an exciting
development in ’big science’ by Anderson [13]. He revealed
the ability to quantitate and detect, in principle, tens of
thousands of proteins in biological samples by 2-D isoelectric
focussing and acrylamide gel electrophoresis. Techniques
borrowed from astronomy and space science were used to
position and quantitate spots formed by dye or radio
location techniques. It is hoped that by building a library
of data intrusion into clinical chemistry will be steady.
Przybylowicz [14] presented an account of the new
multilayer film technology developed by Eastman Kodak.
The instrumentation was also discussed and the advantages
given to the user by simplicity standardisation and freedom
from reagent storage problems were emphasised.
Other symposia focussed on the assessment of the
efficiency of clinical biochemical tests and on standardisation
in clinical chemistry. These areas are clearly of considerable
importance judging bj the number of contributed papers and
posters presented on these subjects. A large number of
Contributed Papers sessions.ran throughout the Congress and
two poster sessions were held daily, and again areas of
current interest were highlighted. A total of Seven Industrial
Seminars were held. A presentation of the past, present and
future of centrifugal analysis was presented by IL [15]
including a contribution by the inventor (Dr. Anderson). The
importance of the technique in minimising the effects of
instrumental drift by rapid sequential spectroscopy was
emphasised and attention was drawn to future developments
in the form of UV transparent rotors, fluorescence measure-
ment and techniques for ESR, blood grouping and coag-
ulation measurement.
Eastman Kodak [16] presented their multilayer film
technology emphasising the care which has been taken to
arrive at sensible precision and accuracy goals for each
analyte and a demonstration of how these goals have been
met in external trade tests in the USA and in Europe.
An indication of the scope of the technology was hinted at
by Dr. E. Przybylowicz who stated that ion-selective
electrode, fluorescence, immunoassay and NAD/NADH
based systems were under development.
Du Pont [17] introduced the ion-specific electrode
attachment for the ACA analyser and their prep -HPLC
sample preparation and, analysis system. The latter device
should prove an invaluable aid in toxicology where a number
of samples must be extracted under carefully controlled
conditions prior to analysis by HPLC.
Other industrial seminars were by Technicon[18] who
introduced the ’STAR’ continuous radioimmunoassay
analyser, Syva 19] who described the EMIT technique, and
LKB Clinicon [20] who presented the ’PRISMA’, their
programmable selective modular analyser.
A most .impressive exhibition of clinical chemistry equip-
ment was mounted on two floors. Exhibits ranged from the
smallest items to aid the manual laboratory worker to
comprehensive multi-channel ana!ysers with on-line data
processing systems. In addition, many books and journals
were on view.
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Undoubtedly the Third European Congress of Clinical
Chemsitry was an outstanding success and served to stimulate
great interest and exchange of views in all the important
areas of clinical chemstiry. The organisation was excellent
and yet never obtrusive and all those who took part are to
be warmly congratulated.
Mark S. Sto ll
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Automation in Clinical
Chemistry
The first international Symposium on Automation in Clinical
Chemistry was held in the Ciudad Sanitaria de la Seguridad
Social Principes de Espana, Barcelona, Spain, from March
7-10 19"79.
The aim of this first meeting in. Spain was to provide an
international forum for the discussion of this important
subject in the context of conditions in Spain and elsewhere.
The presentations and round-table conferences covered three
aspects of the subject: (i) automation as an end in itself,
including the current developments in instrumentation and
computerisation, especially with respect to enzyme and lipid
measurements; (ii) quality control materials and their applic-
ation and use for inter- and intra-laboratory quality control;
(iii) practical examples of the impact of the introduction of
automation. The last day of the meeting was devoted to the
problems of automation in the private laboratory. Compre-
hensive reports of all papers and round table conferences will
be published in: Dto. Analisis Clinicos, C.S.S.S. Principes de
Espaa, Barcelona.
In his opening remarks, the President of the Symposium,
Dr. Fernandez Sim6, Jefe Dto. de Analisis Clinicos, expressed
the hope that all present would speak freely in the lengthy
discussion periods which had been arranged. He introduced
the main speakers who gave papers as follows:
Dr. F.L. Mitchell (Division of Clinical Chemistry, Clinical
Research Centre, Harrow, UK) dealt with the recent advances
in the automation of clinical chemistry, the progress which
has been achieved since the introduction of continuous flow
analysis over 20 years ago, and the difficulties now facing
users because of the considerable choice of instrument-
ation currently available from the new and large industry
which has evolved. He drew attention to the problem of
choice for the large laboratory between a single multi-
channel analyser, and the new small highly versatile stand
alone analysers linked by computer. The versatility and low
price of microprocessors makes it possible to apply computer
control and processing where economic considerations were
previously prohibitive. The impact that the introduction of
layer chemistry will have on almost all types of laboratory
was also discussed.
Dr. R. Jensen (Biologiste des Hpitaux, Hgpital Saint-
Aindr. C.S. Bordeaux) covered the difficulties in directing
the clinical laboratory problems relating to increasing work
and data throughout, and the more stringent controls which
are now required were discussed. He drew attention to four
stages of development which have occurred in his own labor-
atory over the last 25 years: (i) no automation as currently
understood; (ii) the installation of single channel analysers
allowing the daily output of analyses to increase from 250
to 450; (iii) the use of Technicon SMA instruments with
limited computer and data .processing links between the
laboratory and other departments; (iv) the installation of the
Technicon SMAC. The changes necessitated an increase in
the skills required of the laboratory directors. In addition
to the knowledge in medicine and chemistry gained at
university, he must now exercise skills in architecture,
electronics, computer programming, management, psychol-
ogy, etc. Many of these qualities are also required in
technical staff whose selection and training pose increasing
problems.
Dr. A. Corominas (Servicio Anfilisis Clinicos, R.S.S.S.,
Barcelona, Spain) reviewed the automated methods and
systems available for lipid determinations. Selection of the
most appropriate measurement instrument or system to be
used, depends upon the number of samples, the type of
patient and whether preventive medicine or diagnosis and
treatment are received. He enumerated the manual methods
used for the determination of total lipids, lipoproteins and
their components, cholesterol, phospholipids and fatty acids,
particularly concentrating on the variety of methods current-
ly applied to cholesterol assay-fluorimetric, colorimetric,
gravimetric, chromatographic, electrochemical and enzym-
atic. The enzymatic methods for triglyceride determination
were mentioned together with titrimetric, colorimetric,
fluorimetric and radiochemical methods for the measurement
of fatty acids. Finally he discussed the use of lyophilised sera
in quality control.
Dr. J.P. Colombo (Chemisches Zentrallabor-Inselspital,
Bern, Switzerland) confined his discussion to the interaction
between a laboratory computer system and the hospital
information system. Though the functions of both may be
carried out on a centralised data processor, they must be
developed separately, and introduction of the information
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system should be completed in stages depending upon the
various medical and clerical units to be served in the hospital.
In the system described by Dr. Colombo, each unit can
access information depending upon the requirements of the
unit concerned. In its laboratory management role, the
computer receives information from instruments, on- and
off-line. This allows the separate development of individual
instruments. By keeping the hospital information and labor-
atory management roles separate within the single processor,
the autonomy of the laboratory is maintained while allowing
the maximum availability of laboratory information within
the hospital.
Dr. C. Collombel (Biologiste des Hopitaux, Hopital des
Charpennes, Lyon, France) dealt with the problems involved
in the application of automation to the measurement of
enzyme activity. Requirements for this are currently increas-
ing between 20 and 30% per year. The methods of choice are
kinetic and require special attention; automation is necessary
if the reliability and reproducibility of results are to be
achieved and maintained.
In the choice of systems it is important to take into
account the parameters recommended by governmental or
international organisations such as the International Federat-
ion for Clinical Chemistry and the World Health Organis-
ation. The important areas to consider are temperature,
dilution of enzyme, any pre-incubation period, method of
reaction initiation, the method of result calculation from
raw data and the overall time to be allowed for the kinetic
measurement. Based on a comprehensive survey of kinetic
analysers currently available in France, he reviewed the
technical features which influence the performance of the
instrument.
Dr. T.P. Whitehead (Department of Clinical Chemistry,
Queen Elizabeth Medical Centre, Birmingham, U.K.) who
organises the United Kingdom Quality Control Scheme,
explained the evolution of the Scheme over the last decade.
He showed the improvement in the quality of laboratory
output which had ensued. The Scheme indicates the perform-
ance of different methods used for individual types of
analysis and this feature has had a substantial influence upon
the choice of method by the participants. Many foreign
laboratories now take part in the British Scheme. The differ-
ent patterns of control, displayed in other countries is
noteworthy.
Dr. L. Patifio (Warner Lambert International, PO Box
377 Morris Plains, New Jersey, 07950, USA) dealt with the
use of lyophilised serum for quality control in the autom-
ated laboratory. Often large commercial laboratories
producing quality control materials can obtain so-called
’standard’ material by averaging results obtained in many
reference laboratories. Another method of obtaining
analytical values for a batch of material is to average the
results obtained in a quality control scheme with many
participating laboratories. He explained the complexity of
the processes used to obtain the large batches of serarequired,
and indicated in detail the manufacturing procedures designed
to produce the necessary characteristics of a batch control
material.
Dr. A. Furies (Cerba International, Maffliers. 95560
Montsoult, France) discussed the problems of automating
the more esoteric assays such as those for the measurement
of steroids and various drugs in blood and urine. In most
cases only semi-automation is possible, but this is often
extremely valuable, for example, in the extraction of urine.
He described automation used in his laboratory for various
stages in a number of difficult assays. It is usually necessary
to design a system specifically for a certain laboratory. The
various stages can be connected by microprocessor control
which can also monitor quality at selected points in the
system.
Four round-table discussions were organised with some
seven or eight experts participating in each particular field.
All members of the Symposium joined the discussions and
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lively exchanges of views took place.
Dr. F.L. Mitchell presided over the discussion problems
involved in the automation of a large hospital laboratory.
Problems discussed were supply of instruments for normal
rout’;ne measurements and the special requirements for
emergency and paediatric work. The cost-effectiveness of
large expensive machines was considered in comparison to
the efficient operation of small versatile units with a lower
initial capital cost. The merits of centralisation were
discussed in relation to overall operational efficiency.
Dr. R. Galimany (Hospitalet de Llobregat, Barcelona)
explained the present situation in Spanish laboratories where,
because of a lack of information, automation had not
progressed as rapidly as elsewhere.
Lastly, on request, Dr. Mitchell detailed the work of the
Expert Panel on Instrumentation of the International
Federation for Clinical Chemistry. He outlined papers to be
published shortly which Contained. suggestions to be used by
manufacturers in describing their instruments and their
characteristics.
Dr. C. Collombel presided over the discussion of the
automation of the laboratory using non-computerised systems.
The first discourse concerned the presentation of the case for
laboratory automation to a hospital’s management. The
points covered included consideration of the benefits for the
society for which the laboratory functions, the hospital
organisation, the medical staff and finally the staff of the
laboratory itself. It was agreed that above a certain workload,
automation and computerisation must be as complete as
possible, dealing with all procedures from sample collection
to the delivery of results.
Opinions differed as to the degree to which emergency
samples should be integrated into a routine load. It was
agreed that computerisation was beneficial only if considered
for its value in correlating results with the clinical data from
a patient. In discussing staff education, opinions differed as
to whether analysers should be operated by specially trained
technicians, or whether the laboratory staff should be able to
operate them.
Dr. G. Siest presided over the discussion of the applicat-
ion of quality control to the automated laboratory. The
discussants first dealt with the errors originating before a
specimen was analysed. These can be most important and are
difficult, if not impossible to control. Problems were
considered arising from the stability of control materials
during their delivery from manufacturer to laboratory. The
relative merits of human and animal preparations were
discussed together" with the problems produced by lyophilis-
ation and reconstitution of specimens.
The importance and relative merits of both internal and
external control were stressed, particularly the frequency of
inserting specimens for internal quality control. The possibili-
ties of setting up a national quality control scheme for Spain
were also discussed. Professor Whitehead invited all members
of the Symposium to take part in the United Kingdom
Quality Control Scheme for a trial period.
T. Brugerie (Cerba International, Maffliers, 95560
Montsoult, France) presided over the discussions on autom-
ation for a private independent laboratory. Each member of
the round-table dealt with a specific aspect of the function-
ing of an independent laboratory; the technical difficulties
experienced in the operation of many independent labor-
atories were exposed and the profitability of automation as
compared with manual operation was also discussed.
A recent survey by French clinical chemists had shown
that the productivity per laboratory worker does not increase
once a certain workload has been attained. This could be due
mainly to an increasing proportion of specialized tests which
are difficult to automate.
For the introduction of automation into a general pathol-
ogy laboratory it is important to consider separately the
specialities biochemistry, immunology, toxicology, micro-
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biology and haematology and for each to study the numbers
of samples to be processed; the precision and accuracy
required, and the overall time which can be allowed for the
production of results. Computerization of data processing is
extremely cost effective especially when on-line operation is
used. Renting equipment needs careful consideration
especially in relation to the cost for each analysis and the
relationship between total cost and the volume of workload.
In an independent laboratory emergency work includes a
wide range of analyses since it is difficult to control the
selection of tests. Because of this automation needs to be
arranged so that it covers both the emergency and routine
load.
For the rural laboratory screening a population of about
10,000, the first tests to be considered for automation are
for haematology erythrocyte and leucocyte count and
haemoglobin and haematocrit measurement. Though glucose
is more commonly requested, the four haematological tests
are more difficult to complete. The more common biochem-
ical determinations are best done using semi-automation
dispensors, diluters, etc.
R. Galimany and F.L. Mitchell
Analytical Quality Control
This two day meeting, held at Stirling University, Scotland,
on 7-8 June 1979, was a worthy successor to the meeting
held last year at St Andrews when the Automatic Methods
Group (Analytical Division, Chemical Society) also collab-
orated with the Scottish Region and others in the planning
and organisation. An attendance of over 160 delegates fully
justified the hard work put in by local members of the
Scottish Region Committee.
The meeting opened with a plenary address by C.A.
Johnson, of the British Pharmacopoeia Commission, in which
he gave a characteristically witty and discursive survey of the
present state of quality control. He commented unfavourably
on the unneccessarily demanding specifications in step with
improvements in instrumentation and analytical techniques.
Professor A.R. Rogers examined the use made by analysts of
statistics, commenting particularly on the fact that although
they usually received some training in elementary statistical
techniques only rarely were they able to correctly interpret
the results of applying them. J.D. Chamberlain gave an
exposition of Cumulative Sum Techniques (CUSUMS)and
demonstrated their advantages over other control chart
techniques. In a survey of methods of acceptance sampling
R. Caulcutt commented unfavourably on the comprehensi-
bility of BS6001 which was written with the use of technical
terms that limited its utility for analytical chemists and
quality controllers.
T.E.V. Horsley reflected on more than 40 years of quality
control in the pharmaceutical industry and commented,
not altogether favourably, on the increasing complexity of
modern life. He reviewed the many advantages of automation
in pharmaceutical quality control laboratories but said that
experience had taught him that although automation was
essential, one must not lose sight of the valuable specialised
capabilities of the human senses, particularly the eyes and
hands working in conjunction with the brain.
Dr. D. Betteridge surveyed recent developments in the
field of microprocessors with particular emphasis on their
advantages and limitations. He illustrated how micro-
processors allowed analytical chemists to adopt new
approaches to their problems by describing his involvement
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in the development of an automated titrator. He concluded
by describing some of the uses that could be made of micro-
computers such as the PET.
D.E. Faulkner presented a paper that reveiwed the applic-
ation of AutoAnalyzer techniques to the work of the
Wellcome Foundation, paying particular attention to
hardware and alternative methods of data handling.
G.K.E. Copeland described the analytical techniques used
at the Laboratory of the Government Chemist to produce
the cigarette tar and nicotine content league tables that are
published twice a year by the UK Departments of Health. A
fully automated system measures the tar, nicotine, water and
carbon monoxide levels produced by smoking cigarettes on
an automatic machine. Data handling is carried out on a
central computer with instruments linked on-line, this
facilitating the use of analytical quality control techniques.
The second day opened with a plenary lecture from R.
Sawyer, Superintendent of the Food and Nutrition Division
at the Laboratory of the Government Chemist, who
explained the aims of EEC legislation and the work being
carried out to ensure harmonistion. He described the differ-
ing enforcement methods used in the various Common
Market countries and pointed out that the ability of different
countries to put their own interpretation on Directives was
a valuable factor in ensuring their acceptance,, although this
could lead to subsequent problems for the analyst. The
United Kingdom differed from other Common Market
countries who generally favoured the adoption of standard
analytical methods an approach that had not been
favoured in UK legislation in the past. Mr. Sawyer concluded
an interesting, and often amusing, lecture with some personal
thoughts on the need for the quality control of EEC
legislation.
The three following papers from S.J. Anderson, S.V.
Ayers and J.E. Pentelow surveyed the use of quality control
in the beer, wine and plastic packaging industries respecti-
ively.
Professor G. Ghersini, from Milan, described some novel
control charts that he had developed to assist the monitoring
of radionuclide levels in the electrical power generating
industry. He was followed by T.C. Foster.who described the
problems of making consistent additions to animal feedstuffs
formulations. The meeting concluded with a paper from G.A.
Best who gave an account of analytical quality control
methods used in the laboratories of the Clyde River Purific-
ation Board and the workings of the Harmonised Monitoring
Scheme.
Advantage was taken of the proximity to Gleneagles to
round off the meeting by holding the second Technicon Golf
Tournament at the conclusion of the scientific programme.
A dozen golfers accompanied by about sixteen enthusiastic
spectators spent an enjoyable few hours on the 18 holes of
the King’s Course. During the ensuing dinner at Blairlogie
House Hotel the prizes were presented by David Thomson on
behalf of the Technicon Instrument Co. Ltd. The first
prize, and the handsome Technicon Golf Trophy, went to
Dr. B.J. Woodhall of ICI Pharmaceutical Division, the second
prize to Mr. D.J. Evans of Smith, Kline and French and the
third prize to Dr. A.G. Davidson of Strathclyde University.
The hotly contested booby prize went to R.N. Thornhill of
Smith, Kline and French.
D. Porter
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